Kirkland & Ellis Advises Francisco Partners and Aesynt Incorporated in Sale of Aesynt to Omnicell, Inc.

Kirkland & Ellis advises private equity firm Francisco Partners and Aesynt Incorporated, a provider of automated medication management systems, in connection with the sale of Aesynt to Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions to healthcare systems, for $275 million. The acquisition will create the broadest product portfolio in the industry with significant offerings in automated dispensing systems, central pharmacy robotics, IV robotics and enterprise analytics. To read more about the transaction, please click here.
 
The Kirkland team was led by corporate partners Adam D. Phillips and Alex S. Kaufman; tax partner Keith E. Villmow; debt finance partner Christopher W. Kirkham; intellectual property partner John Lynn; employee benefits partner Jack N. Bernstein; and labor and employment partner Edward Holzwanger.